Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PA › Wilkes Barre › NPI 1255585303
Hospital

Wilkes Barre Hospital Company LLC

Wilkes Barre Hospital Company LLC was paid $7.41M by Medicaid between Jan 2018 and Dec 2024, across 258 billing codes. Its largest line is 99284, emergency room visit (serious) — 25% of everything it billed.

33Billing provider infoWILKES BARRE HOSPITAL COMPANY LLC
WILKES BARRE, PA 18702
33aNPI1255585303assigned 11/14/2008
28Total paid$7.41M
24GClaims306,138
24DCodes billed258
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Pennsylvania

Rank by total paid#44 of 154
Median peer was paid$2.82M
This provider vs. median2.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20181,065$28K
20191,646$36K
202034,798$704K
2021148,693$3.27M
202243,241$1.19M
202343,834$1.21M
2024incomplete32,861$978K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 25% 18,823 17,907 $1.85M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 15% 14,867 14,353 $1.14M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 7.9% 10,022 9,476 $588K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 7.3% 4,885 4,686 $540K
G0378 Hospital observation service, per hour 4.2% 458 424 $312K
80053 Comprehensive metabolic panel 3.9% 30,957 28,892 $292K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 3.9% 4,068 3,781 $291K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.0% 31,925 29,515 $152K
84443 Thyroid stimulating hormone (TSH) 1.6% 6,289 6,125 $121K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.4% 2,184 2,109 $104K
70450 Computed tomography, head or brain; without contrast material 1.3% 1,792 1,739 $96K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.1% 1,054 1,034 $79K
246 more codes
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 6,853 $68K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 2,869 $68K
80061 Lipid panel <1% 5,488 $62K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 429 $60K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 1,840 $57K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,648 $50K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 5,529 $42K
77067 Screening mammography, bilateral, including computer-aided detection <1% 534 $39K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 772 $39K
71045 Radiologic examination, chest; single view <1% 5,556 $37K
96361 Intravenous infusion, hydration; each additional hour <1% 2,467 $36K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 2,225 $36K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 1,055 $32K
0012A <1% 731 $30K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 839 $29K
84702 <1% 1,847 $28K
80048 Basic metabolic panel (calcium, ionized) <1% 4,045 $28K
87086 Culture, bacterial; quantitative colony count, urine <1% 4,447 $28K
G0379 Direct admission of patient for hospital observation care <1% 26 $27K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 2,185 $27K
81001 <1% 11,431 $27K
84703 <1% 2,713 $26K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 206 $24K
84484 <1% 3,270 $24K
83735 <1% 4,117 $23K
80050 General health panel <1% 572 $22K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 896 $20K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 387 $20K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 507 $19K
83036 Hemoglobin; glycosylated (A1C) <1% 3,393 $19K
36415 Collection of venous blood by venipuncture <1% 14,130 $18K
85027 <1% 3,070 $18K
80074 <1% 357 $17K
0240U <1% 603 $17K
71046 Radiologic examination, chest; 2 views <1% 1,523 $17K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 107 $17K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 758 $16K
72125 Computed tomography, cervical spine; without contrast material <1% 303 $16K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 329 $15K
85610 <1% 5,507 $15K
76641 <1% 268 $15K
96375 Therapeutic injection; each additional sequential IV push <1% 1,169 $15K
76830 Ultrasound, transvaginal <1% 313 $13K
86780 <1% 885 $13K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 487 $13K
88342 <1% 498 $12K
84439 <1% 1,846 $12K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 439 $12K
83690 <1% 2,833 $11K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 361 $11K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 469 $11K
93975 <1% 99 $11K
76536 <1% 281 $11K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 239 $10K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 310 $10K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,272 $10K
77063 Screening digital breast tomosynthesis, bilateral <1% 513 $10K
83880 <1% 435 $10K
93971 <1% 167 $10K
71250 <1% 190 $10K
87040 <1% 847 $9K
82607 <1% 837 $9K
87070 <1% 1,295 $8K
82728 <1% 817 $8K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 172 $8K
85730 <1% 1,418 $8K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 51 $8K
84153 <1% 350 $8K
84481 <1% 344 $7K
74018 <1% 563 $7K
71275 Computed tomographic angiography, chest, with contrast material <1% 40 $7K
84403 <1% 252 $7K
70486 <1% 122 $6K
93970 <1% 97 $6K
T1015 A visit at a community health center or clinic (one all-in rate) <1% 219 $6K
86850 <1% 860 $6K
97161 <1% 167 $6K
83540 <1% 899 $6K
81025 <1% 1,659 $6K
83605 <1% 1,030 $6K
93880 <1% 101 $6K
87186 <1% 792 $5K
86803 <1% 306 $5K
76775 <1% 175 $5K
73564 <1% 297 $5K
84146 <1% 224 $5K
82043 <1% 817 $5K
97035 <1% 627 $5K
82077 <1% 1,184 $5K
82570 <1% 838 $5K
93017 <1% 172 $4K
72100 <1% 250 $4K
77065 Tomosynthesis, mammo <1% 88 $4K
87077 <1% 682 $4K
80164 <1% 264 $4K
86618 <1% 197 $4K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 490 $4K
86762 <1% 227 $4K
73610 <1% 249 $4K
82248 <1% 683 $4K
86038 <1% 299 $4K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 26 $4K
88313 <1% 212 $4K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 12 $4K
0002A <1% 91 $4K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 59 $4K
82550 <1% 649 $4K
73030 <1% 320 $4K
86140 <1% 1,343 $3K
86900 <1% 1,059 $3K
86901 <1% 1,059 $3K
77066 Tomosynthesis, mammo <1% 42 $3K
87522 Neg quan hep c or qual rna <1% 87 $3K
87340 <1% 255 $3K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 169 $3K
82746 <1% 315 $3K
0011A <1% 70 $3K
70551 Magnetic resonance imaging, brain; without contrast material <1% 15 $3K
76642 <1% 82 $3K
85379 <1% 331 $3K
73630 <1% 293 $3K
72110 <1% 146 $3K
73130 <1% 263 $3K
84144 <1% 159 $3K
72131 <1% 45 $3K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 45 $3K
83001 <1% 145 $2K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 14 $2K
90715 <1% 180 $2K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 58 $2K
83550 <1% 574 $2K
83525 <1% 203 $2K
85652 <1% 848 $2K
84436 <1% 260 $2K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 47 $2K
97150 Therapeutic procedure(s), group (2 or more individuals) <1% 346 $2K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 141 $2K
80076 <1% 252 $2K
82105 <1% 103 $2K
82784 <1% 101 $2K
82150 <1% 478 $2K
88360 <1% 63 $2K
87088 <1% 258 $2K
86317 <1% 69 $2K
83970 <1% 57 $2K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 12 $1K
80178 <1% 221 $1K
84402 <1% 57 $1K
82950 <1% 232 $1K
84550 <1% 313 $1K
86431 <1% 212 $1K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 82 $1K
73502 <1% 101 $1K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 34 $1K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 226 $1K
73110 <1% 126 $1K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 147 $1K
82962 <1% 975 $1K
80069 <1% 158 $1K
72040 <1% 81 $1K
83002 <1% 62 $1K
80143 <1% 223 $883.00
84425 <1% 142 $878.72
84100 <1% 207 $855.45
82330 <1% 98 $828.08
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 2,682 $825.58
96376 <1% 17 $821.52
86696 <1% 32 $805.71
80179 <1% 196 $772.12
82140 <1% 206 $771.33
93226 <1% 25 $719.44
84590 <1% 63 $715.35
86695 <1% 33 $704.17
82977 <1% 90 $694.93
J1170 Injection, hydromorphone, up to 4 mg <1% 372 $671.98
82565 <1% 114 $650.86
J2704 Injection, propofol, 10 mg <1% 3,375 $649.66
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 47 $639.34
83655 <1% 62 $633.50
88341 <1% 15 $612.54
84156 <1% 214 $601.97
77061 <1% 12 $553.52
86787 <1% 28 $511.66
82670 <1% 25 $502.12
0001A <1% 12 $500.00
86255 <1% 30 $481.66
12001 <1% 24 $469.24
12011 <1% 13 $444.19
73140 <1% 47 $413.80
85018 <1% 175 $412.66
83721 <1% 42 $390.91
71100 <1% 26 $374.57
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 2,665 $339.78
94726 <1% 12 $329.76
88304 <1% 136 $305.45
97165 <1% 13 $274.70
85014 <1% 102 $267.19
J2270 Injection, morphine sulfate, up to 10 mg <1% 295 $257.84
72050 <1% 12 $242.41
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,690 $240.40
J2060 Injection, lorazepam, 2 mg <1% 580 $235.31
73080 <1% 18 $214.36
72072 <1% 12 $213.23
93225 <1% 13 $212.20
84479 <1% 30 $190.21
82785 <1% 12 $186.66
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,127 $176.90
84466 <1% 14 $162.83
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 12 $162.33
82378 <1% 12 $159.15
84520 <1% 32 $152.25
82951 <1% 12 $145.67
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 32 $145.19
82947 <1% 42 $143.53
80177 <1% 14 $141.71
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 192 $138.83
87147 <1% 41 $135.45
J0690 Injection, cefazolin sodium, 500 mg <1% 770 $129.02
87081 <1% 25 $126.36
A9537 Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries <1% 12 $123.12
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 1,679 $118.96
J1630 Injection, haloperidol, up to 5 mg <1% 100 $114.96
73090 <1% 12 $111.15
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 308 $109.47
73590 <1% 13 $105.14
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 3,642 $103.07
87486 <1% 12 $98.64
86376 <1% 13 $98.52
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 73 $67.63
J1650 Injection, enoxaparin sodium, 10 mg <1% 148 $53.83
85045 <1% 14 $51.55
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 131 $48.87
J0780 Injection, prochlorperazine, up to 10 mg <1% 16 $47.14
97116 <1% 15 $46.52
82040 <1% 12 $41.60
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 26 $36.48
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 37 $33.66
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 125 $26.09
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 40 $10.49
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 171 $1.15
91301 <1% 358 $0.03
J0131 Injection, acetaminophen, not otherwise specified,10 mg 0% 69 $0.00
J1030 Injection, methylprednisolone acetate, 40 mg 0% 26 $0.00
36430 0% 18 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 122 $0.00
91300 0% 38 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
Same official

Other billing entities under LALOR, PAULA

Full network →
ProviderLocationPaid
Roswell Hospital CorporationRoswell, NM$41.27M
Wesley Health System LLCHattiesburg, MS$37.82M
Metro Knoxville Hma LLCPowell, TN$28.70M
Bullhead City Hospital CorporationBullhead City, AZ$28.54M
Iom Health System LPFort Wayne, IN$27.50M
ST. Joseph Health System, LLCFort Wayne, IN$25.43M
Laredo Texas Hospital Company LPLaredo, TX$19.46M
Oak Hill Hospital CorporationOak Hill, WV$18.77M
Cocke County Hma, LLCNewport, TN$18.34M
Cleveland Tennessee Hospital Company LLCCleveland, TN$16.31M
Jefferson County Hma LLCJefferson City, TN$14.31M
Northwest Arkansas Hospitals, LLCSpringdale, AR$11.46M
Petersburg Hospital Company LLCPetersburg, VA$11.20M
Campbell County Hma, LLCLafollette, TN$10.07M
Warsaw Health System LLCWarsaw, IN$9.95M
Longview Medical Center LPLongview, TX$9.29M
Moberly Hospital Company LLCMoberly, MO$8.61M
Crestview Hospital Company, LLCCrestview, FL$8.15M
Kirksville Missouri Hospital Company, LLCKirksville, MO$7.98M
Victoria of Texas LPVictoria, TX$7.74M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.